13 天
Asianet Newsable on MSNLabcorp Gains Citi Upgrade While Quest Diagnostics Faces Downgrade On Margin Concerns ...A Wall Street analyst issued contrasting ratings on Tuesday for two major diagnostic testing companies, upgrading shares of ...
Quest Diagnostics Inc. DGX benefits from its robust utilization of the Advanced Diagnostics portfolio offerings. The company also expands through strategic acquisitions, completing eight ...
Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...
Competitive Landscape: Quest Diagnostics faces intense competition, primarily from LabCorp, other commercial laboratories and hospitals. While pricing is an important factor in choosing a testing ...
Fresenius Medical (FMS) and Quest Diagnostics (DGX) announced that, under terms of a definitive acquisition agreement, Quest will acquire select assets of FME’s wholly owned Spectra Laboratories ...
NEW YORK – Kidney dialysis firm Fresenius Medical Care said Monday that it is selling select laboratory assets to Quest Diagnostics. Quest is acquiring select assets of Fresenius' Spectra Laboratories ...
The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果